Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
Mojsak MN, Abdelrazek S, Szumowski P, Rogowski F, Sykała M, Kostecki J, Kociura-Sawicka A, Jurgilewicz D, Myśliwiec J.
Nucl Med Rev Cent East Eur. 2016;19(1):3-11. doi: 10.5603/NMR.2016.0002.
PMID:26841373
Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer.
Bignell GR, Canzian F, Shayeghi M, Stark M, Shugart YY, Biggs P, Mangion J, Hamoudi R, Rosenblatt J, Buu P, Sun S, Stoffer SS, Goldgar DE, Romeo G, Houlston RS, Narod SA, Stratton MR, Foulkes WD.
Am J Hum Genet. 1997 Nov;61(5):1123-30. doi: 10.1086/301610.
PMID:9345104
Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome.